Delivery Order SPE2DB20D3103-SPE2DB22FN9T6

Award Date 6/17/22
Potential Completion Date 6/21/22
Potential Value $19K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $26,938.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of Nurtec ODT 75 mg tablets, a medication used for the acute treatment of migraine. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to...
This federal contract award, valued at $19,727.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. This contract is not set aside and was awarded through open competition. Amerisourcebergen Drug...
This federal contract award, valued at $17,769.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is not set-aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $20,976.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Nurtec ODT 75 mg tablets, a medication used for treating migraines. The contract has an ultimate completion date of October 14, 2021 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $27,277.47 and a completion date of September 20, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,255.59 firm fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of May 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $3,784.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Nurtec ODT 75 mg tablets, a medication used for the treatment of migraines. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and is open to competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,008.04 Delivery Order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Firm Fixed Price arrangement with a completion date of May 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,778.79 firm fixed-price delivery order is for Nurtec ODT 75 mg tablets, a medication used for the treatment of migraine. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $18,027.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Nurtec ODT 75 mg tablets, a prescription medication used to treat migraines. The contract has a firm fixed-price pricing type and an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN9T6
    Delivery Order

This federal contract award, with a ceiling value of $18,860.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a prescription medication used to treat migraine.

The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, the prime contractor, is a subsidiary of the parent company Cencora, Inc., which also holds an IDC with the Department of Justice Federal Bureau of Investigation valued at up to $750,000 through May 2024 for similar medical products and prescription drugs.

Generated 2/27/25, 12:25 PM